Molar Pregnancy Survivor Shares Her Rare Cancer Story

July 29th 2021, 12:00am

By Michelle Velez

It wasn’t just a miscarriage, it was a rare type of cancer called choriocarcinoma.

Opdivo Regimen Pulled for Liver Cancer Treatment

July 28th 2021, 11:00pm

By Brielle Benyon

Opdivo was granted an accelerated approval for patients with hepatocellular carcinoma, but the indication was pulled after follow-up data failed to show that the agent improved survival over another drug.

Navigating Chronic Lymphocytic Leukemia Diagnosis and Staging

July 28th 2021, 9:00pm

By Darlene Dobkowski, MA

Although CLL follows a different staging format than other cancer types, diagnosing the disease properly can open the doors for more effective treatment and management strategies.

‘Treadmill of Survivorship’ With a Supportive Oncology Nurse

July 28th 2021, 6:00pm

By Janie McCutchen

A patient with ovarian cancer details the compassion she experienced with her oncology nurse even during the COVID-19 pandemic.

Stereotactic Body Radiation Therapy May Be the 'Ticket' For Inflamed Lymph Nodes

July 28th 2021, 4:00pm

By Julie S. Brokaw

An ovarian cancer survivor shares her experience receiving a radiation treatment on her lymph nodes.

Training for a Marathon: Managing Health After an MPN Diagnosis

July 28th 2021, 3:00pm

By Antonia DePace

Maintaining health before and after a diagnosis of myeloproliferative neoplasms could help patients as they undergo treatment.

Precision Medicine and Clinical Trials

July 28th 2021, 2:04pm

Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.

Biomarker Testing: Centralized Vs Local Labs

July 28th 2021, 1:58pm

The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.

Researchers Identify Biomarker to Predict Immunotherapy Response in Patients With Breast Cancer

July 28th 2021, 1:00pm

By Jamie Cesanek

The Major Histocompatibility Complex Class II protein has potential to predict immunotherapy benefit in two types of breast cancer.

Novel App Informs Patients With Cancer of Unknown Primary

July 27th 2021, 9:00pm

By Antonia DePace

An online tool developed by oncologists for this rare diagnosis individualizes survival estimates, resulting in candid discussions and better decision-making.

Giving Hope: Research on Rare Head and Neck Cancer Treatment Options

July 27th 2021, 6:00pm

By Antonia DePace

Study findings from China show that a new treatment option improves survival outcomes in nasopharyngeal carcinoma, but can U.S. populations expect similar results?

Searching For My Cancer Words

July 27th 2021, 4:00pm

By Martha Carlson

“Each of us has our own way of marking what cancer brings to our lives, sometimes in a simple three-letter word,” writes a woman with breast cancer.

Pain Management Has Worsened for Patients With Late-Stage Cancer

July 27th 2021, 3:00pm

By Brielle Benyon

Fewer opioids have been prescribed, but there have been more emergency room visits for pain in patients with cancer who have poor prognoses.

Role of Combination Therapy in RCC Management

July 27th 2021, 2:13pm

Dr Thomas E. Hutson comments on the rationale for using combination immune therapy, as well as a combination of immune therapy and an oral VEGF inhibitor for initial treatment of RCC.

Managing Adverse Events in RCC

July 27th 2021, 2:09pm

Kidney cancer expert, Dr Thomas E. Hutson, shares insight on managing adverse events resulting from combination therapy in RCC.